dosing
Articles tagged with “dosing”
Microdosing Ketamine Protocols: Sub-Therapeutic Dose Approaches
A detailed exploration of ketamine microdosing protocols, including rationale, dosing ranges, clinical applications, safety considerations, and how microdosing compares to standard sub-anesthetic dosing for depression and chronic pain.
Standard IV Ketamine Infusion Protocols for Treatment-Resistant Depression
A comprehensive overview of intravenous ketamine infusion protocols used in clinical settings for treatment-resistant depression, including dosing parameters, session structure, monitoring requirements, and evidence-based best practices.
Dosing and Administration
Common questions about ketamine dosing, routes of administration, weight-based calculations, dose adjustments, and the differences between clinic and at-home treatment.
Weight-Based Dosing Guidelines for Low-Dose Ketamine
Practical guidance on weight-based dosing calculations for low-dose ketamine across clinical indications. Addresses ideal versus actual body weight considerations, dosing ranges by route and indication, and special population adjustments.
Tracking Treatment Response to Ketamine: PHQ-9, MADRS, and Clinical Scales
A clinician's guide to systematic outcome measurement in ketamine therapy, covering validated rating scales, assessment frequency, response and remission thresholds, and data-driven decision-making for dosing adjustments.
What Is the Standard Ketamine Dose for Depression?
The standard ketamine dose for depression is 0.5 mg/kg administered intravenously over 40 minutes.
Defining Sub-Anesthetic Ketamine: Dose Ranges and Therapeutic Windows
Comprehensive guide to sub-anesthetic ketamine dose ranges and therapeutic windows, covering pharmacological thresholds, receptor occupancy, and clinical dose-response relationships.
Renal and Hepatic Dose Adjustments for Low-Dose Ketamine
Pharmacokinetic rationale and clinical guidelines for ketamine dose adjustments in patients with renal impairment or hepatic dysfunction, including monitoring strategies and contraindication thresholds.
Pharmacokinetics of Ketamine: Absorption, Distribution, Metabolism, and Elimination
A comprehensive overview of ketamine pharmacokinetics across all clinically relevant routes of administration. Covers bioavailability, volume of distribution, hepatic metabolism via CYP enzymes, half-life considerations, and the role of active metabolites.
Pediatric Low-Dose Ketamine: Dosing Considerations and Safety
Review of pediatric low-dose ketamine dosing considerations, covering developmental pharmacokinetics, age-specific safety data, and clinical applications in children and adolescents.
Ketamine Tolerance: Understanding Dose Adjustments Over Time
A clinical review of tolerance development during repeated ketamine treatment, covering pharmacological mechanisms of tolerance, clinical indicators, evidence-based dose adjustment strategies, and the distinction between therapeutic tolerance and treatment failure.
Optimizing Oral Ketamine Bioavailability: Pharmacokinetic Strategies
Pharmacokinetic strategies for optimizing oral ketamine bioavailability, including sublingual administration, formulation approaches, metabolic inhibition, and clinical considerations.
What Is Ketamine's Half-Life?
Ketamine has a plasma half-life of approximately 2 to 3 hours, though its antidepressant effects persist far longer due to downstream neuroplastic changes.
How Many Ketamine Treatments Are Needed?
A typical initial course of ketamine therapy consists of 6 IV infusions over 2 to 3 weeks, followed by maintenance treatments as needed.
Esketamine vs Racemic Ketamine Dosing: Comparative Pharmacology
Comparative pharmacology of esketamine versus racemic ketamine dosing, examining enantiomer-specific receptor binding, clinical potency differences, and dosing equivalencies.
Dose-Response Relationships in Low-Dose Ketamine Therapy
An in-depth examination of ketamine dose-response curves across indications including depression, chronic pain, and procedural analgesia. Covers threshold doses, ceiling effects, and how response varies with clinical context.
Low-Dose Ketamine Case Studies: Clinical Outcomes and Lessons
Five anonymized clinical case studies illustrating treatment outcomes with low-dose ketamine across treatment-resistant depression, PTSD, chronic pain, and bipolar depression, with detailed dosing, timelines, and clinical lessons.
Geriatric Considerations in Low-Dose Ketamine Therapy
Clinical guidance on low-dose ketamine use in elderly patients, addressing age-related pharmacokinetic changes, cardiovascular risk stratification, cognitive monitoring, and dose modifications.
Ready to learn more?
Explore our comprehensive guides and tools to help you navigate your ketamine therapy journey.